ARS Pharmaceuticals, Inc.
SPRY$466M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSAN DIEGO162 employees
Drugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jun 15, 2026
13wMarket Overview
Stock performance and key metrics
SPRY News
Catalyst Timeline
1 upcoming, 1 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ARS-1 | Phase 2 | Asthma | - | - |
0.5 mg epinephrine | Phase 2 | Urticaria Chronic | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply